Digestive Tolerance of Maltitol and FOS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-30

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Digestive symptoms following consumption of low digestibe carbohydrates are generally assessed product by product but several ingredients can be used simultaneously. The study aimed at evaluating to digestive tolerance of maltitol and FOS used in a same food.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Glycaemic and Insulinaemic Responses After Consumption of FOS.

NCT02353403

Glycaemia

COMPLETED NA

Evaluation of Carbohydrates Part 2

NCT03293706

Gastro-Intestinal Tolerance

COMPLETED NA

Plasma Glucose Kinetics and Cereal Product Content in Slowly Digestible Starch (SDS) in Healthy Volunteers

NCT02323542

Blood Glucose Kinetics

COMPLETED NA

Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies

NCT05827198

Gastrointestinal Tolerance Healthy Population

UNKNOWN NA

A Study Assessing the Tolerable Upper Intake Level and Safety of Sugars From Fiber

NCT05051202

Gastrointestinal Tolerance

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Digestive Tolerance in Healthy Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

sugary dessert cream

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

maltitol alone

Group Type EXPERIMENTAL

maltitol alone

Intervention Type OTHER

maltitol 85% / FOS 15%

Group Type EXPERIMENTAL

maltitol 85% / FOS15%

Intervention Type OTHER

maltitol 68% / FOS 32%

Group Type EXPERIMENTAL

maltitol 68% / FOS 32%

Intervention Type OTHER

maltitol 50% / FOS 50%

Group Type EXPERIMENTAL

maltitol 50% / FOS 50%

Intervention Type OTHER

FOS alone

Group Type EXPERIMENTAL

FOS alone

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

maltitol 85% / FOS15%

Intervention Type OTHER

maltitol alone

Intervention Type OTHER

maltitol 68% / FOS 32%

Intervention Type OTHER

maltitol 50% / FOS 50%

Intervention Type OTHER

FOS alone

Intervention Type OTHER

Placebo

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI between 18.5 and 30
* normal and regular stool frequency: at least 3 stools per week and no more than 3 per days
* subjects not sufferinf from a metabolic, functional or inflammatory disease affecting intestinal transit and nutrients absorption
* subjects not sufferinf from IBS according to Rome III criteria
* subjects not using mdeiction which could affect nutrients absoprtion